Female smokers beyond the perimenopausal period are at increased risk of chronic pulmonary disease: A systematic review and meta-analysis

Respiratory Research

Volumn 7, Issue , 2006, Pages

  Gan, Wen Qi ^a   Man, S F Paul ^a   Postma, Dirkje S ^b   Camp, Patricia ^a   Sin, Don D ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLIMACTERIUM; COHORT ANALYSIS; COMPARATIVE STUDY; DATA ANALYSIS; EVIDENCE BASED PRACTICE; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; LINEAR REGRESSION ANALYSIS; LUNG FUNCTION; MALE; POPULATION RESEARCH; PREDICTION; REVIEW; RISK ASSESSMENT; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW; ADULT; AGED; INCIDENCE; META ANALYSIS; MIDDLE AGED; PATHOPHYSIOLOGY; POSTMENOPAUSE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTOR; SMOKING;

ADULT; AGE FACTORS; AGED; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PERIMENOPAUSE; POSTMENOPAUSE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SEX FACTORS; SMOKING;

EID: 33645775057     PISSN: 1465993X     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-7-52     Document Type: Review

References (47)

1. Murray CJ, Lopez AD: Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997, 349:1498-1504.
2. Brown CA, Crombie IK, Tunstall-Pedoe H: Failure of cigarette smoking to explain international differences in mortality from chronic obstructive pulmonary disease. J Epidemiol Community Health 1994, 48:134-139.
3. Michaud CM, Murray CJ, Bloom BR: Burden of disease - implications for future research. JAMA 2001, 285:535-539.
4. Sullivan SD, Ramsey SD, Lee TA: The economic burden of COPD. Chest 2000, 117:5S-9S.
5. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC: Chronic obstructive pulmonary disease surveillance - United States, 1971-2000. MMWR Surveill Summ 2002, 51:1-16.
6. Zorrilla-Torras B, Garcia-Marin N, Galan-Labaca I, Gandarillas-Grande A: Smoking attributable mortality in the community of Madrid: 1992-1998. Eur J Public Health 2005, 15:43-50.
7. U.S. Department Af Health and Human Services: Reducing tobacco use: a report of the Surgeon General. Atlanta, Georgia: U.S. Department of Health and Human Services, CDC; 2000.
8. Centers for Disease control: Cigarette Smoking Among Adults - United States. 2003 [http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5420a3.htm#tab].
9. Gillum RF: Frequency of attendance at religious services and cigarette smoking in American women and men: The Third National Health and Nutrition Examination Survey. Prev Med 2005, 41:607-613.
10. Fletcher C, Peto R: The natural history of chronic airflow obstruction. Br Med J 1977, 1:1645-1648.
11. Pauwels RA, Rabe KF: Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 2004, 364:613-620.
12. Chinn S, Jarvis D, Melotti R, Luczynska C, Ackermann-Liebrich U, Anto JM, Cerveri I, de Marco R, Gislason T, Heinrich J, Janson C, Kunzli N, Leynaert B, Neukirch F, Schouten J, Sunyer J, Svanes C, Vermeire P, Wjst M, Burney P: Smoking cessation, lung functionA and weight gain: a follow-up study. Lancet 2005, 365:1629-1635.
13. Rijcken B, Schouten JP, Xu X, Rosner B, Weiss ST: Airway hyperresponsiveness to histamine associated with accelerated decline in FEV1. Am J Respir Crit Care Med 1995, 151:1377-1382.
14. Jedrychowski W, Krzyzanowski M, Wysocki M: Changes in lung function determined longitudinally compared with decline assessed cross-sectionally. The Cracow Study. Eur J Epidemiol 1986, 2:134-138.
15. James AL, Palmer LJ, Kicic E, Maxwell PS, Lagan SE, Ryan GF, Musk AW: Decline in lung function in the Busselton Health Study: The effects of asthma and cigarette smoking. Am J Respir Crit Care Med 2005, 171:109-114.
16. Tashkin DP, Clark VA, Coulson AH, Simmons M, Bourque LB, Reems C, Detels R, Sayre JW, Rokaw SN: The UCLA population studies of chronic obstructive respiratory disease. VIII. Effects of smoking cessation on lung function: A prospective study of a free-living population. Am Rev Respir Dis 1984, 130:707-715.
17. Sherrill DL, Enright P, Cline M, Burrows B, Lebowitz MD: Rates of decline in lung function among subjects who restart cigarette smoking. Chest 1996, 109:1001-1005.
18. Xu X, Dockery DW, Ware JH, Speizer FE, Ferris BG Jr: Effects of cigarette smoking on rate of loss of pulmonary function in adults: A longitudinal assessment. Am Rev Respir Dis 1992, 146:1345-1348.
19. Vestbo J, Prescott E, Lange P: Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group. Am J Respir Crit Care Med 1996, 153:1530-1535.
20. Griffith KA, Sherrill DL, Siegel EM, Manolio TA, Bonekat HW, Enright PL: Predictors of loss of lung function in the elderly: The Cardiovascular Health Study. Am J Respir Crit Care Med 2001, 163:61-68.
21. Hankinson JL, Odencrantz JR, Fedan KB: Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999, 159:179-187.
22. Viegi G, Sherrill DL, Carrozzi L, Di Pede F, Baldacci S, Pistelli F, Enright P: An 8-year follow-up of carbon monoxide diffusing capacity in a general population sample of northern italy. Chest 2001, 120:74-80.
23. Connett JE, Murray RP, Buist AS, Wise RA, Bailey WC, Lindgren PG, Owens GR, Lung Health Study Research Group: Changes in smoking status affect women more than men: Results of the Lung Health Study. Am J Epidemiol 2003, 157:973-979.
24. Prescott E, Bjerg AM, Andersen PK, Lange P, Vestbo J: Gender difference in smoking effects on lung function and risk of hospitalization for COPD: Results from a Danish longitudinal population study. Eur Respir J 1997, 10:822-827.
25. Lange P, Nyboe J, Appleyard M, Jensen G, Schnohr P: Relation of ventilatory impairment and of chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes. Thorax 1990, 45:579-585.
26. Downs SH, Brandli O, Zellweger JP, Schindler C, Kunzli N, Gerbase MW, Burdet L, Bettschart R, Zemp E, Frey M, Keller R, Tschopp JM, Leuenberger P, Ackermann-Liebrich U, SAPALDIA team: Accelerated decline in lung function in smoking women with airway obstruction: SAPALDIA 2 cohort study. Respir Res 2005, 6:45.
27. Patel BD, Luben RN, Welch AA, Bingham SA, Khaw KT, Day NE, Lomas DA, Wareham NJ: Childhood smoking is an independent risk factor for obstructive airways disease in women. Thorax 2004, 59:682-686.
28. Xu X, Li B, Wang L: Gender difference in smoking effects on adult pulmonary function. Eur Respir J 1994, 7:477-483.
29. Silverman EK, Chapman HA, Drazen JM, Weiss ST, Rosner B, Campbell EJ, O'Donnell WJ, Reilly JJ, Ginns L, Mentzer S, Wain J, Speizer FE: Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis. Am J Respir Crit Care Med 1998, 157:1770-1778.
30. Scanlon PD, Connett JE, Waller LA, Altose MD, Bailey WC, Buist AS: Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000, 161:381-390.
31. Gold DR, Wang X, Wypij D, Speizer FE, Ware JH, Dockery DW: Effects of cigarette smoking on lung function in adolescent boys and girls. N Engl J Med 1996, 335:931-937.
32. Barnes PJ, Shapiro SD, Pauwels RA: Chronic obstructive pulmonary disease: Molecular and cellular mechanisms. Eur Respir J 2003, 22:672-688.
33. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, Pare PD: The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004, 350:2645-2653.
34. Sin DD, Man SF: Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 2003, 107:1514-1519.
35. Hutchinson WL, Koenig W, Frohlich M, Sund M, Lowe GD, Pepys MB: Immunoradiometric assay of circulating C-reactive protein: Age-related values in the adult general population. Clin Chem 2000, 46:934-938.
36. Gan WQ, Man SF, Sin DD: The interactions between cigarette smoking and reduced lung function on systemic inflammation. Chest 2005, 127:558-564.
37. Tashkin DP, Altose MD, Bleecker ER, Connett JE, Kanner RE, Lee WW, Wise R: The lung healtA study: airway responsiveness to inhaled methacholine in smokers with mild to moderate airflow limitation. The Lung Health Study Research Group. Am Rev Respir Dis 1992, 145:301-310.
38. Leynaert B, Bousquet J, Henry C, Liard R, Neukirch F: Is bronchial hyperresponsiveness more frequent in women than in men? A population-based study. Am J Respir Crit Care Med 1997, 156:1413-1420.
39. Paoletti P, Carrozzi L, Viegi G, Modena P, Ballerin L, Di Pede F, Grado L, Baldacci S, Pedreschi M, Vellutini M: Distribution of bronchial responsiveness in a general population: Effect of sex, age, smoking, and level of pulmonary function. Am J Respir Crit Care Med 1995, 151:1770-1777.
40. Tashkin DP, Altose MD, Connett JE, Kanner RE, Lee WW, Wise RA: Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group. Am J Respir Crit Care Med 1996, 153:1802-1811.
41. Hospers JJ, Postma DS, Rijcken B, Weiss ST, Schouten JP: Histamine airway hyper-responsiveness and mortality from chronic obstructive pulmonary disease: A cohort study. Lancet 2000, 356:1313-1317.
42. Baron JA, La Vecchia C, Levi F: The antiestrogenic effect of cigarette smoking in women. Am J Obstet Gynecol 1990, 162:502-514.
43. Carlson CL, Cushman M, Enright PL, Cauley JA, Newman AB, Cardiovascular Health Study Research Group: Hormone replacement therapy is associated with higher FEVI in elderly women. Am J Respir Crit Care Med 2001, 163:423-428.
44. Mueller JE, Frye C, Brasche S, Heinrich J: Association of hormone replacement therapy with bronchial hyper-responsiveness. Respir Med 2003, 97:990-992.
45. Skobeloff EM, Spivey WH, St Clair SS, Schoffstall JM: The influence of age and sex on asthma admissions. JAMA 1992, 268:3437-3440.
46. Hibbert ME, Couriel JM, Landau LI: Changes in lung, airway, and chest wall function in boys and girls between 8 and 12 yr. J Appl Physiol 1984, 57:304-308.
47. Merkus PJ, Borsboom GJ, Van Pelt W, Schrader PC, Van Houwelingen HC, Kerrebijn KF, Quanjer PH: Growth of airways and air spaces in teenagers is related to sex but not to symptoms. J Appl Physiol 1993, 75:2045-2053.